REPL
Replimune Group, Inc.
Latest Form 4:Sale$148KbyXynos Konstantinos (Chief Medical Officer) · filed Aug 12, 2026
Replimune Group, Inc. (REPL) has 24 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 12, 2026.
The most active filer is Chief Commercial Officer Sarchi Christopher with 3 filings. Insiders have net sold $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Sushil Patel
- Employees:465
- HQ:Woburn, MA, US
- IPO:2018-07-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$1.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 11,447 | $148K | Aug 12 | SEC ↗ | |
| Chief Executive Officer | Sale | 39,341 | $510K | Aug 12 | SEC ↗ | |
| Chief Accounting Officer | Sale | 7,632 | $99K | Aug 12 | SEC ↗ | |
| Chief Financial Officer | Sale | 11,448 | $148K | Aug 12 | SEC ↗ | |
| Chief Commercial Officer | Sale | 12,000 | $111K | Jun 4 | SEC ↗ | |
Xynos KonstantinosFirst filing | Chief Medical Officer | Sale | 14,023 | $71K | May 20 | SEC ↗ |
Hill Emily LuisaFirst filing | Chief Financial Officer | Sale | 7,812 | $40K | May 20 | SEC ↗ |
| Chief Commercial Officer | Sale | 8,626 | $44K | May 20 | SEC ↗ | |
Astley-Sparke PhilipFirst filing | Director | Sale | 17,657 | $90K | May 20 | SEC ↗ |
Patel SushilFirst filing | Chief Executive Officer | Sale | 37,324 | $190K | May 20 | SEC ↗ |
Schwendenman AndrewFirst filing | Chief Accounting Officer | Sale | 7,894 | $40K | May 20 | SEC ↗ |
Sarchi ChristopherFirst filing | Chief Commercial Officer | Sale | 6,500 | $52K | Apr 6 | SEC ↗ |
Related companies
Replimune Group, Inc. is in the Healthcare sector.